SlideShare uma empresa Scribd logo
1 de 36
Baixar para ler offline
Look Alike And Sound Alike
Medications
Look Alike And Sound Alike
8/8/2017 1
Pharmacist/ Yasir A. Alowayyidh
Pharmaceutical Care Administration, Medina
DEFINITION OF LASA
8/8/2017 2
FACTORS OF ERROR WITH LASA
CATEGORIES IN LASA
FDA AND ISMP LISTS OF LASA
Strategies to avoid errors with LASA
involve medications that are visually similar in physical appearance or
packaging and names of medications that have spelling similarities and/or
similar phonetics
These confusing drug names are one of the main causes of medication error,
There are many sound and look alike drugs that would result in medication error.
These errors may cause harm or even death to patients.
DEFINITION
Look Alike Sound Alike (LASA)
8/8/2017 3
Individual factors take into capabilities, limitations, and
characteristics, such as, illegible handwriting, knowledge deficit, etc.
Environmental factors work environment or within the workflow
process, such as drug storage, environmental distractions, drug
shortage, etc.
Unique factors are special characteristics to look-alike/sound-alike
drug themselves, such as similar dose, similar indication, same
ingredients available in multiple formulations, etc.
FACTORS OF ERROR IN ALSL
The main reasons for improper dispensing of confusing drug names ,
may due to lack of knowledge of registered pharmacist or due to less number of
pharmacist during rush hours.
INDIVIDUAL FACTORS
ENVIRONMENTAL FACTORS
UNIQUE FACTORS
https://www.ismp-canada.org/download/PharmacyConnection/PC2014-02
4
LASA drugs-Similar brand names, different generic drugs
Losec® (OMEPRAZOLE) &Lasix® (furosemide)
LASA drugs- Similar brand names , same generic drug
CETRALON ® and CETRO ®, (CETIRIZINE HYDROCHLORIDE )
LASA drugs- Similar brand names with additional letter
Fevadol , Fevadol Plus, FEVADOL EXTRA FEVADOL COLD & FLU
LASA drugs- Similar brand names of the Antibiotics group
CIFLOX ® (CIPROFLOXACIN) , MOXIFLOX ® (MOXIFLOXACIN)
Categories OF LASA
that can easily cause confusion while prescribing, dispensing and
administration ,
LASA drugs- Same drug, different Dosage forms
VOLTAREN® Tablet ,SUPP , Gel , eye Drops , ampules ……
LASA drugs- Same drug, different release characteristics
( NIFEDIPINE ) ADALAT RETARD ® , ADALAT LA
LASA drugs- Same brand or Generic name, different composition
Amphotericin B (Abelcet®)
Liposomal Amphotericin B (AmBisome®)
LASA drugs- Generic Drug pairs
VINCRISTINE VINBLASTINE
EPHEDRINE EPINEPHRINE
LORAZEPAM CLONAZEPAM
Categories OF LASA ( CONT.)
FDA and ISMP Lists of
Look-Alike Drug Names with Recommended Tall Man Letters
FDA
The US Food and Drug Administration
(FDA) list of drug names with
recommended tall man letters was
initiated in 2001 with the agency’s Name
Differentiation Project
ISMP institute for Safe Medication Practices
Since 2008, ISMP has maintained a list of drug
name pairs and trios with recommended, bolded
tall man (uppercase) letters to help draw attention
to the dissimilarities in look-alike drug names.
The list includes mostly generic-generic drug name
pairs, although a few brand-brand or brand-generic
name pairs are included.
8/8/2017 7
The ISMP list is not an official
list approved by FDA.
It is intended for voluntary
use by healthcare
practitioners and drug
information and technology
vendors.
ISMP
Lorem ipsum dolor sit
amet, consectetur
adipiscing elit, sed do
eiusmod tempor
incididunt ut labore et
dolore magna aliqua.
8/8/2017 8
Any manufacturers’ product
label changes require FDA
approval.
8/8/2017 9
ISMP Confused
Drug name List
https://www.ismp.org/Tools/confus
eddrugnames.pdf
8/8/2017 10
Strategies to avoid errors
with LASA
Monitoring
Information
Patient Education
Procurement
Storage
Dispensing
Prescribing
Administration
Procurement
Minimise the availability of multiple medicines
strengths , avoid similar packaging and appearance
compare them with existing packaging.
Dispensing/Supply
Storage
Use Tall Man lettering to emphasise differences in medications with
sound-alike
Use additional warning labels for look-alike medicines. Warning labels
should be uniform throughout the respective facility to facilitate
identification.
Prescribing
Administration
Monitoring
Information
Patient
Education
Strategies to avoid errors
with LASA
8/8/2017 12
Minimise the availability
of multiple medicines
strengths , avoid similar
packaging and
appearance compare
them with existing
packaging.
Strategies to avoid errors
with LASA
Procurement
8/8/2017 13
 Use Tall Man lettering to emphasise
 labels for look-alike medication.
 locations separate from each other
Strategies to avoid errors
with LASA
Storage
8/8/2017 14
 using both the brand , generic names ,
dosage form, dose and indication for use.
 computerized prescriber order entry (CPOE) should
used Tall Man lettering.
 Minimize the use of Verbal and Telephone orders.
Strategies to avoid errors
with LASA
Prescribing
8/8/2017 15
 Identify medicines based on its name and strength and not by its
appearance or location.
 Double checking should be conducted during the dispensing and
supply process.
 Highlight changes in medication appearances to patients upon dispensing
Dispensing
Strategies to avoid errors
with LASA
8/8/2017 16
(a) Read carefully the label each time a medication is
prior to administration.
(b) Check the purpose of the medication and the dose
prior to administration
Strategies to avoid errors
with LASA
Administration
8/8/2017 17
 Monitor new drugs added to the hospital formulary as they are
released and provide guidelines to These new drugs.
 Monitor patients who may have received wrong medications
as result of LASA medication error..
Strategies to avoid errors
with LASA
Monitoring
8/8/2017 18
 Update healthcare professionals of changes on the list of LASA and
confusing drug names.
 Provide education on LASA medications to healthcare professionals
at orientation and as part of continuing education
Strategies to avoid errors
with LASA
Information
8/8/2017 19
 Inform patients on changes in medication appearances.
 Encourage patients to learn the names of their medications.
Strategies to avoid errors
with LASA
Patient Education
8/8/2017 20
Example of the Strategies to avoid errors
with LASA in KFHM
8/8/2017 21
8/8/2017 22
8/8/2017 23
8/8/2017 24
8/8/2017 25
DAPSONE 100 MG
SODIUM BICARBONATE
375MG
FLUDROCORTISONE 0.1MG
8/8/2017 26
8/8/2017 27
Risperidone
2 mg
8/8/2017 28
Ampoule
8/8/2017 29
8/8/2017 30
8/8/2017 31
8/8/2017 32
8/8/2017 33
Real incident
8/8/2017 34
Reminders, Checklists, Double Checks” and “Rules &
Policies” are used to remind or control people
not necessarily to fix systems.
“Education & Information” is an important strategy
when it is combined with other that strengthen the
system.
Take Home Message
8/8/2017 35
04-lookalikeandsoundalikemedications-170808084616 (2).pdf

Mais conteúdo relacionado

Mais procurados

LASA drugs
LASA  drugs LASA  drugs
LASA drugs
Dr. Vir Vikram
 
Medication documentation and safety
Medication documentation and safetyMedication documentation and safety
Medication documentation and safety
Marcus Hart
 

Mais procurados (20)

Medication Error
Medication ErrorMedication Error
Medication Error
 
Medication error
Medication errorMedication error
Medication error
 
Medication error
Medication errorMedication error
Medication error
 
lookalikeandsoundalikemedications-180319055839.pptx
lookalikeandsoundalikemedications-180319055839.pptxlookalikeandsoundalikemedications-180319055839.pptx
lookalikeandsoundalikemedications-180319055839.pptx
 
Medication errors
Medication errorsMedication errors
Medication errors
 
What is a ‘medication error’
What is a ‘medication error’What is a ‘medication error’
What is a ‘medication error’
 
Lasa drugs final ppt (1).pptx medcell
Lasa drugs final ppt (1).pptx medcellLasa drugs final ppt (1).pptx medcell
Lasa drugs final ppt (1).pptx medcell
 
High - Alert Medications.pptx
High - Alert Medications.pptxHigh - Alert Medications.pptx
High - Alert Medications.pptx
 
Good Dispensing Practice
Good Dispensing PracticeGood Dispensing Practice
Good Dispensing Practice
 
Medication administration - NABH ( Dhananjay Pratap )
Medication administration - NABH  ( Dhananjay Pratap )Medication administration - NABH  ( Dhananjay Pratap )
Medication administration - NABH ( Dhananjay Pratap )
 
Medication error
Medication errorMedication error
Medication error
 
Medication errors
Medication errors Medication errors
Medication errors
 
Avoiding medication error
Avoiding medication         errorAvoiding medication         error
Avoiding medication error
 
Labelling and administration of medicines
Labelling and administration of medicinesLabelling and administration of medicines
Labelling and administration of medicines
 
High Alert Medication
High Alert MedicationHigh Alert Medication
High Alert Medication
 
Introduction to dispensing and medication counseling
Introduction to dispensing and medication counselingIntroduction to dispensing and medication counseling
Introduction to dispensing and medication counseling
 
LASA drugs
LASA  drugs LASA  drugs
LASA drugs
 
Medication error- In Multidisciplinary Hospital
Medication error- In Multidisciplinary HospitalMedication error- In Multidisciplinary Hospital
Medication error- In Multidisciplinary Hospital
 
Medication documentation and safety
Medication documentation and safetyMedication documentation and safety
Medication documentation and safety
 
Medication errors ppt
Medication errors pptMedication errors ppt
Medication errors ppt
 

Semelhante a 04-lookalikeandsoundalikemedications-170808084616 (2).pdf

Syriges color code.docx
Syriges color code.docxSyriges color code.docx
Syriges color code.docx
defence
 
Ranveer verma (Group-17)SIW Pharmacoepidemiology.pptx
Ranveer verma (Group-17)SIW Pharmacoepidemiology.pptxRanveer verma (Group-17)SIW Pharmacoepidemiology.pptx
Ranveer verma (Group-17)SIW Pharmacoepidemiology.pptx
RanveerKumarVerma
 
Principles Of Drug Information 2008
Principles Of Drug Information 2008Principles Of Drug Information 2008
Principles Of Drug Information 2008
brosenthal
 

Semelhante a 04-lookalikeandsoundalikemedications-170808084616 (2).pdf (20)

Syriges color code.docx
Syriges color code.docxSyriges color code.docx
Syriges color code.docx
 
SALA Drugs in India
SALA Drugs in IndiaSALA Drugs in India
SALA Drugs in India
 
Lectures 01 Pharmacology & its Branches/ Divisions Drug and drug nomenclature...
Lectures 01 Pharmacology & its Branches/ Divisions Drug and drug nomenclature...Lectures 01 Pharmacology & its Branches/ Divisions Drug and drug nomenclature...
Lectures 01 Pharmacology & its Branches/ Divisions Drug and drug nomenclature...
 
Abbreviation Pharmacology
Abbreviation PharmacologyAbbreviation Pharmacology
Abbreviation Pharmacology
 
Ranveer verma (Group-17)SIW Pharmacoepidemiology.pptx
Ranveer verma (Group-17)SIW Pharmacoepidemiology.pptxRanveer verma (Group-17)SIW Pharmacoepidemiology.pptx
Ranveer verma (Group-17)SIW Pharmacoepidemiology.pptx
 
Introduction to Pharmacology, Source, Nomenclature& use of Herbal Drugs prect...
Introduction to Pharmacology, Source, Nomenclature& use of Herbal Drugs prect...Introduction to Pharmacology, Source, Nomenclature& use of Herbal Drugs prect...
Introduction to Pharmacology, Source, Nomenclature& use of Herbal Drugs prect...
 
High Alert & Look-Alike/Sound-Alike Medications
High Alert & Look-Alike/Sound-Alike MedicationsHigh Alert & Look-Alike/Sound-Alike Medications
High Alert & Look-Alike/Sound-Alike Medications
 
High alert & lasa medications
High alert & lasa medicationsHigh alert & lasa medications
High alert & lasa medications
 
High alert & lASA medications
High alert & lASA medicationsHigh alert & lASA medications
High alert & lASA medications
 
Prescription off ppt.pptx pharmaceutics ppt
Prescription off ppt.pptx pharmaceutics pptPrescription off ppt.pptx pharmaceutics ppt
Prescription off ppt.pptx pharmaceutics ppt
 
Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...
Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...
Anatomic Therapeutic Chemical Classification, Defined daily dose, Drug utilis...
 
Sổ tay thuốc thú y - tra liều thuốc thú y
Sổ tay thuốc thú y - tra liều thuốc thú ySổ tay thuốc thú y - tra liều thuốc thú y
Sổ tay thuốc thú y - tra liều thuốc thú y
 
Draft Policy on Brand Name Analysis
Draft Policy on Brand Name AnalysisDraft Policy on Brand Name Analysis
Draft Policy on Brand Name Analysis
 
Medication errors
Medication errorsMedication errors
Medication errors
 
Licencing & drug recall of 2014 & 2015
Licencing & drug recall of 2014  & 2015 Licencing & drug recall of 2014  & 2015
Licencing & drug recall of 2014 & 2015
 
Patient safety program LASA & HAM (updated).pptx
Patient safety program LASA & HAM (updated).pptxPatient safety program LASA & HAM (updated).pptx
Patient safety program LASA & HAM (updated).pptx
 
Medication safety lecture 1
Medication safety lecture 1Medication safety lecture 1
Medication safety lecture 1
 
Pharmacological classification of Drug by KD Tripathi.pdf
Pharmacological classification of Drug  by KD Tripathi.pdfPharmacological classification of Drug  by KD Tripathi.pdf
Pharmacological classification of Drug by KD Tripathi.pdf
 
Pharmacological Classification of Drugs with Doses and Preparations ( PDFDriv...
Pharmacological Classification of Drugs with Doses and Preparations ( PDFDriv...Pharmacological Classification of Drugs with Doses and Preparations ( PDFDriv...
Pharmacological Classification of Drugs with Doses and Preparations ( PDFDriv...
 
Principles Of Drug Information 2008
Principles Of Drug Information 2008Principles Of Drug Information 2008
Principles Of Drug Information 2008
 

Mais de ssuser497f37

introduction_to_principles_of_pharmacology.ppt
introduction_to_principles_of_pharmacology.pptintroduction_to_principles_of_pharmacology.ppt
introduction_to_principles_of_pharmacology.ppt
ssuser497f37
 

Mais de ssuser497f37 (20)

Therapeutic drug monitoring PHARMACY sAA.ppt
Therapeutic drug monitoring PHARMACY sAA.pptTherapeutic drug monitoring PHARMACY sAA.ppt
Therapeutic drug monitoring PHARMACY sAA.ppt
 
3.pptx
3.pptx3.pptx
3.pptx
 
99994138.ppt
99994138.ppt99994138.ppt
99994138.ppt
 
Medical Terminology 1.ppt
Medical Terminology 1.pptMedical Terminology 1.ppt
Medical Terminology 1.ppt
 
مخطط.pdf
مخطط.pdfمخطط.pdf
مخطط.pdf
 
parmacok15.ppt
parmacok15.pptparmacok15.ppt
parmacok15.ppt
 
IDSA641.PPT
IDSA641.PPTIDSA641.PPT
IDSA641.PPT
 
introduction_to_principles_of_pharmacology.ppt
introduction_to_principles_of_pharmacology.pptintroduction_to_principles_of_pharmacology.ppt
introduction_to_principles_of_pharmacology.ppt
 
4_2017_10_19!10_00_11_AM.pptx
4_2017_10_19!10_00_11_AM.pptx4_2017_10_19!10_00_11_AM.pptx
4_2017_10_19!10_00_11_AM.pptx
 
iminjectables_rhonda.ppt
iminjectables_rhonda.pptiminjectables_rhonda.ppt
iminjectables_rhonda.ppt
 
Pharmacokinetics (1).ppt
Pharmacokinetics (1).pptPharmacokinetics (1).ppt
Pharmacokinetics (1).ppt
 
6254187.ppt
6254187.ppt6254187.ppt
6254187.ppt
 
3391549.ppt
3391549.ppt3391549.ppt
3391549.ppt
 
3391549.ppt
3391549.ppt3391549.ppt
3391549.ppt
 
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdfroleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
roleofhospitalpharmacistsintransitionsofcare-130301172100-phpapp01 (1).pdf
 
Analytical_Chemistry.pdf
Analytical_Chemistry.pdfAnalytical_Chemistry.pdf
Analytical_Chemistry.pdf
 
11472874.ppt
11472874.ppt11472874.ppt
11472874.ppt
 
5666367.ppt
5666367.ppt5666367.ppt
5666367.ppt
 
11241869.ppt
11241869.ppt11241869.ppt
11241869.ppt
 
4494047.ppt
4494047.ppt4494047.ppt
4494047.ppt
 

Último

Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 

Último (20)

Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 

04-lookalikeandsoundalikemedications-170808084616 (2).pdf

  • 1. Look Alike And Sound Alike Medications Look Alike And Sound Alike 8/8/2017 1 Pharmacist/ Yasir A. Alowayyidh Pharmaceutical Care Administration, Medina
  • 2. DEFINITION OF LASA 8/8/2017 2 FACTORS OF ERROR WITH LASA CATEGORIES IN LASA FDA AND ISMP LISTS OF LASA Strategies to avoid errors with LASA
  • 3. involve medications that are visually similar in physical appearance or packaging and names of medications that have spelling similarities and/or similar phonetics These confusing drug names are one of the main causes of medication error, There are many sound and look alike drugs that would result in medication error. These errors may cause harm or even death to patients. DEFINITION Look Alike Sound Alike (LASA) 8/8/2017 3
  • 4. Individual factors take into capabilities, limitations, and characteristics, such as, illegible handwriting, knowledge deficit, etc. Environmental factors work environment or within the workflow process, such as drug storage, environmental distractions, drug shortage, etc. Unique factors are special characteristics to look-alike/sound-alike drug themselves, such as similar dose, similar indication, same ingredients available in multiple formulations, etc. FACTORS OF ERROR IN ALSL The main reasons for improper dispensing of confusing drug names , may due to lack of knowledge of registered pharmacist or due to less number of pharmacist during rush hours. INDIVIDUAL FACTORS ENVIRONMENTAL FACTORS UNIQUE FACTORS https://www.ismp-canada.org/download/PharmacyConnection/PC2014-02 4
  • 5. LASA drugs-Similar brand names, different generic drugs Losec® (OMEPRAZOLE) &Lasix® (furosemide) LASA drugs- Similar brand names , same generic drug CETRALON ® and CETRO ®, (CETIRIZINE HYDROCHLORIDE ) LASA drugs- Similar brand names with additional letter Fevadol , Fevadol Plus, FEVADOL EXTRA FEVADOL COLD & FLU LASA drugs- Similar brand names of the Antibiotics group CIFLOX ® (CIPROFLOXACIN) , MOXIFLOX ® (MOXIFLOXACIN) Categories OF LASA that can easily cause confusion while prescribing, dispensing and administration ,
  • 6. LASA drugs- Same drug, different Dosage forms VOLTAREN® Tablet ,SUPP , Gel , eye Drops , ampules …… LASA drugs- Same drug, different release characteristics ( NIFEDIPINE ) ADALAT RETARD ® , ADALAT LA LASA drugs- Same brand or Generic name, different composition Amphotericin B (Abelcet®) Liposomal Amphotericin B (AmBisome®) LASA drugs- Generic Drug pairs VINCRISTINE VINBLASTINE EPHEDRINE EPINEPHRINE LORAZEPAM CLONAZEPAM Categories OF LASA ( CONT.)
  • 7. FDA and ISMP Lists of Look-Alike Drug Names with Recommended Tall Man Letters FDA The US Food and Drug Administration (FDA) list of drug names with recommended tall man letters was initiated in 2001 with the agency’s Name Differentiation Project ISMP institute for Safe Medication Practices Since 2008, ISMP has maintained a list of drug name pairs and trios with recommended, bolded tall man (uppercase) letters to help draw attention to the dissimilarities in look-alike drug names. The list includes mostly generic-generic drug name pairs, although a few brand-brand or brand-generic name pairs are included. 8/8/2017 7
  • 8. The ISMP list is not an official list approved by FDA. It is intended for voluntary use by healthcare practitioners and drug information and technology vendors. ISMP Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 8/8/2017 8
  • 9. Any manufacturers’ product label changes require FDA approval. 8/8/2017 9
  • 10. ISMP Confused Drug name List https://www.ismp.org/Tools/confus eddrugnames.pdf 8/8/2017 10
  • 11. Strategies to avoid errors with LASA Monitoring Information Patient Education Procurement Storage Dispensing Prescribing Administration
  • 12. Procurement Minimise the availability of multiple medicines strengths , avoid similar packaging and appearance compare them with existing packaging. Dispensing/Supply Storage Use Tall Man lettering to emphasise differences in medications with sound-alike Use additional warning labels for look-alike medicines. Warning labels should be uniform throughout the respective facility to facilitate identification. Prescribing Administration Monitoring Information Patient Education Strategies to avoid errors with LASA 8/8/2017 12
  • 13. Minimise the availability of multiple medicines strengths , avoid similar packaging and appearance compare them with existing packaging. Strategies to avoid errors with LASA Procurement 8/8/2017 13
  • 14.  Use Tall Man lettering to emphasise  labels for look-alike medication.  locations separate from each other Strategies to avoid errors with LASA Storage 8/8/2017 14
  • 15.  using both the brand , generic names , dosage form, dose and indication for use.  computerized prescriber order entry (CPOE) should used Tall Man lettering.  Minimize the use of Verbal and Telephone orders. Strategies to avoid errors with LASA Prescribing 8/8/2017 15
  • 16.  Identify medicines based on its name and strength and not by its appearance or location.  Double checking should be conducted during the dispensing and supply process.  Highlight changes in medication appearances to patients upon dispensing Dispensing Strategies to avoid errors with LASA 8/8/2017 16
  • 17. (a) Read carefully the label each time a medication is prior to administration. (b) Check the purpose of the medication and the dose prior to administration Strategies to avoid errors with LASA Administration 8/8/2017 17
  • 18.  Monitor new drugs added to the hospital formulary as they are released and provide guidelines to These new drugs.  Monitor patients who may have received wrong medications as result of LASA medication error.. Strategies to avoid errors with LASA Monitoring 8/8/2017 18
  • 19.  Update healthcare professionals of changes on the list of LASA and confusing drug names.  Provide education on LASA medications to healthcare professionals at orientation and as part of continuing education Strategies to avoid errors with LASA Information 8/8/2017 19
  • 20.  Inform patients on changes in medication appearances.  Encourage patients to learn the names of their medications. Strategies to avoid errors with LASA Patient Education 8/8/2017 20
  • 21. Example of the Strategies to avoid errors with LASA in KFHM 8/8/2017 21
  • 26. DAPSONE 100 MG SODIUM BICARBONATE 375MG FLUDROCORTISONE 0.1MG 8/8/2017 26
  • 35. Reminders, Checklists, Double Checks” and “Rules & Policies” are used to remind or control people not necessarily to fix systems. “Education & Information” is an important strategy when it is combined with other that strengthen the system. Take Home Message 8/8/2017 35